Fludarabine Phosphate 25 mg/mL (Fludarabine Phosphate INJECTION, SOLUTION) 25 mg/mL

Fludarabine Phosphate 25 mg/mL is an injectable solution used for specific medical treatments. This intravenous solution is designed for precise administration and is manufactured by Sagent Pharmaceuticals in the USA.

Strength

25 mg/mL

Pack Size

1 VIAL in 1 CARTON (25021-242-02) / 2 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fludarabine Phosphate is primarily used in the treatment of certain types of cancer. It works by interfering with the growth of cancer cells. Patients often wonder, 'What is Fludarabine Phosphate used for?' This medication is typically prescribed for conditions that require targeted therapy to slow or stop the proliferation of abnormal cells.

Side Effects

Common effects of Fludarabine Phosphate may include fatigue, nausea, and a higher susceptibility to infections. Some patients may experience a decrease in blood cell counts, which can lead to bruising or bleeding more easily. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Fludarabine Phosphate should be handled with care, as it is a potent medication. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be aware of potential side effects and report any severe reactions immediately.

Avoid Interactions

Fludarabine Phosphate may interact with other medications, particularly those that suppress the immune system or affect blood cell production. It is crucial to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain over-the-counter drugs may also impact the effectiveness and safety of Fludarabine Phosphate.

Frequently Asked Questions

Fludarabine Phosphate is used in the treatment of certain types of cancer, particularly those affecting the blood and lymphatic system.

Fludarabine Phosphate is administered intravenously, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include fatigue, nausea, and an increased risk of infections. Some patients may also experience a decrease in blood cell counts.

Fludarabine Phosphate may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Patients should follow the prescribed dosage and administration instructions carefully and monitor for any unusual symptoms.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.